四川医学
四川醫學
사천의학
Sichuan Medical Journal
2015年
10期
1368-1370
,共3页
汤壮%曹德宏%魏强%鄢世兵
湯壯%曹德宏%魏彊%鄢世兵
탕장%조덕굉%위강%언세병
肾盂癌%输尿管癌%病理%预后
腎盂癌%輸尿管癌%病理%預後
신우암%수뇨관암%병리%예후
renal pelvic carcinoma%ureteral carcinoma%diagnosis%treatment
目的 了解肾盂癌合并输尿管癌的临床特点. 方法 对四川大学华西医院2002至2012年收治的28例肾盂癌合并输尿管癌患者的临床资料进行回顾性研究分析. 结果 本研究纳入男性患者19例,女性患者9例,平均发病年龄66. 9岁. 血尿及腰部症状为最常见症状. 28例患者全部行输尿管癌根治术. 术后病理诊断均为尿路上皮癌,部分患者伴有鳞癌及腺癌. 28例均获得随访,随访时间为1~31月,平均19月. 术后总2年生存率33. 3%,Tis、Ta、T1、T2期50%,T3为23%,T4期0%;低级别尿路上皮癌50%,高级别尿路上皮癌33. 3%. 结论 肾盂癌合并输尿管癌患者具有更高的病理分期和分级,且预后更差,早期发现、早期诊断和治疗是提高远期生存率的重要因素.
目的 瞭解腎盂癌閤併輸尿管癌的臨床特點. 方法 對四川大學華西醫院2002至2012年收治的28例腎盂癌閤併輸尿管癌患者的臨床資料進行迴顧性研究分析. 結果 本研究納入男性患者19例,女性患者9例,平均髮病年齡66. 9歲. 血尿及腰部癥狀為最常見癥狀. 28例患者全部行輸尿管癌根治術. 術後病理診斷均為尿路上皮癌,部分患者伴有鱗癌及腺癌. 28例均穫得隨訪,隨訪時間為1~31月,平均19月. 術後總2年生存率33. 3%,Tis、Ta、T1、T2期50%,T3為23%,T4期0%;低級彆尿路上皮癌50%,高級彆尿路上皮癌33. 3%. 結論 腎盂癌閤併輸尿管癌患者具有更高的病理分期和分級,且預後更差,早期髮現、早期診斷和治療是提高遠期生存率的重要因素.
목적 료해신우암합병수뇨관암적림상특점. 방법 대사천대학화서의원2002지2012년수치적28례신우암합병수뇨관암환자적림상자료진행회고성연구분석. 결과 본연구납입남성환자19례,녀성환자9례,평균발병년령66. 9세. 혈뇨급요부증상위최상견증상. 28례환자전부행수뇨관암근치술. 술후병리진단균위뇨로상피암,부분환자반유린암급선암. 28례균획득수방,수방시간위1~31월,평균19월. 술후총2년생존솔33. 3%,Tis、Ta、T1、T2기50%,T3위23%,T4기0%;저급별뇨로상피암50%,고급별뇨로상피암33. 3%. 결론 신우암합병수뇨관암환자구유경고적병리분기화분급,차예후경차,조기발현、조기진단화치료시제고원기생존솔적중요인소.
Objective To investigate the clinical characteristics of renal pelvic carcinoma associated with ureteral carci-noma patients who underwent surgical therapy in the West China Hospital of Sichuan University. Methods Retrospectively ana-lyze the data of 28 cases were proved with renal pelvic carcinoma associated with ureteral carcinoma by pathology. Results The study included 19 male and 9 female patients. The average age of morbidity was 66. 9 years old. All the 28 cases underwent nephroureterectomy. The pathology diagnosis were confirmed with urological epithelial carcinoma and some patients were associated with adenocarcinoma or squamous cell carcinoma. All the 28 cases were followed up from 1-31months. The 2 year survival rates of Tis、Ta、T1、T2 was 50%,of T3 was 23%,of T4 was 0%. Conclusion Renal pelvic carcinoma associated with ureteral carcinoma have a very poor prognosis. The early diagnosis,treatment are the key points for the prognosis of patients with this rare kind of dis-ease.